CRISPR Therapeutics AG (CRSP)
Industry Biotechnology
This stock can be held in an Investment ISA and an Investment Account
Sell
$38.26
Buy
$38.41
$-0.345 (-0.92%)
Prices updated at 28 May 2025, 09:29 EDT
| Prices minimum 15 mins delay
Prices in USD
CRISPR Therapeutics AG is a gene editing company. It is engaged in the development of CRISPR/Cas9-based therapeutics.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
$38.13 - $37.17 | |
$67.88 - $30.04 | |
- | |
3,214.89m | |
- | |
- | |
1,174 | |
1.76 | |
1,686,086.36 | |
1.83 | |
85.91m | |
CH0334081137 | |
-4.49 | |
- |
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.